Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CHWY vs GSK✓SelectedUSD · GSKCHWY vs GSK performance historyLatest closeAs of-4.27%11/20
Stock and ETF performance explorer

CHWY vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-70.5%
GSK return
+40.7%
Excess return
-111.1%
Maximum drawdown
-78.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.3%-0.1%-4.1%-4.2%
7D-13.4%-5.3%-8.1%-12.6%
30D-8.6%-3.7%-4.9%-7.9%
3M-18.3%-7.3%-11.1%-17.4%
6M-3.3%-4.2%+0.9%-2.7%
YTD-41.0%+0.9%-41.9%-41.1%
1Y-41.1%+7.3%-48.4%-41.8%
3Y-5.2%+52.7%-58.0%-13.3%
All-70.5%+40.7%-111.1%-71.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling